•宣佈與ArcelorMittal S.A.簽署了分爲兩階段的乙醇購銷協議。“ArcelorMittal”), a biorefining licensee of the Company, including off-take contracts for one-year and five-year terms
•Announced Project Drake, a 3000萬 gallon per year, EU-based, ethanol-to-sustainable aviation fuel project in tandem with the payment of a non-refundable fee in consideration for the Company’s grant of exclusivity to a new aviation infrastructure-focused financial partner with the intent of finalizing a financing commitment by the end of 2024
•Reported revenue of $990萬 for third-quarter 2024 as compared to revenue of $1740萬 and $1960萬 for second-quarter 2024 and third-quarter 2023, respectively. Sequential decrease driven by timing delay in anticipated LanzaJet, Inc. (“LanzaJet”) sublicensing event that was expected to result in approximately $800萬 of licensing revenue. Year-over-year decrease driven primarily by higher engineering services revenue related to a specific project being completed in third-quarter 2023
•Provided details on wide-range of potential financial outcomes for fourth-quarter 2024 based on several sizeable initiatives underway with varying degrees of timing uncertainty
•Expanding business model to complement licensing business by developing and financing more of LanzaTech's own projects with infrastructure capital partners, which enables LanzaTech to potentially own more of the biorefining value chain, including greater involvement with produced ethanol
•Actively evaluating material cost reduction opportunities as well as opportunities to reallocate resources to focus on and accelerate commercial activities
•Announced the expansion of the Company's biorefining capabilities to produce a single-cell protein called LanzaTech Nutritional Protein. The estimated $1萬億 alternative protein market is expected to grow significantly, and the Company's nutrient-rich product is designed to be a suitable ingredient for animal feed, pet food, and human nutrition that can be produced from CO2, oxygen and hydrogen anywhere in the world. LanzaTech's bioreactors have been producing protein as a co-product to ethanol for years, and now the Company has developed the capability to produce protein as the primary product.
•Added eight projects to the early-stage engineering phase of the Company’s project development pipeline. In September 2024, LanzaTech announced the signing of a master licensing agreement with SEKISUI which resulted in a related project being moved out of the advanced engineering stage and into the stage where an FID evaluation package is being prepared. Additionally, LanzaTech advanced its project with NTPC in India into the post-FID and construction phase, and continues to expect that several additional projects currently in advanced engineering will achieve FID and move into the construction phase over the next 12 months.
4
截至2024年3月31日,我們的現金及現金等價物爲750萬美元。
As of September 30, 2024, LanzaTech had $8910萬 in total cash, restricted cash, and investments, compared to total cash of $7580萬 at the end of second-quarter 2024. The sequential increase in cash is attributable to the 4000萬美元 capital raise LanzaTech closed in August 2024, net of cash used during the quarter.
Post September 30, 2024, LanzaTech made a $1000萬 settlement payment to one of the two parties involved in the Forward Purchase Agreement (「FPA」) that was put in place in 2023. It was the Company’s decision to fully satisfy our obligations to this party under the FPA in cash in order to: (1) reduce the number of outstanding common shares, and (2) limit future downward pressure on the stock price in the event that this party were to sell its equity position in LanzaTech on the open market. LanzaTech had the option to settle part of the payment in shares, but as of the date of the settlement, a settlement in common shares per the terms of the FPA would have valued the shares at a discount to the market price.
Fourth-quarter and Full-year 2024 Financial Outlook
Given several large initiatives in various stages of development and finalization, outcomes for fourth-quarter and full-year 2024 financial results create a wide range of potential outcomes. Potential revenue drivers for fourth-quarter 2024 are comprised of the following key components that have varying degrees of associated timing uncertainty: